ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · IEX Real-Time Price · USD
8.66
-0.07 (-0.80%)
At close: Jul 2, 2024, 4:00 PM
9.63
+0.97 (11.20%)
After-hours: Jul 2, 2024, 7:30 PM EDT
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $839.11 million as of July 2, 2024. Its market cap has increased by 39.88% in one year.
Market Cap
839.11M
Enterprise Value
615.70M
1-Year Change
39.88%
Ranking
Category
Stock Price
$8.66
Market Cap Chart
Since December 4, 2020, ARS Pharmaceuticals's market cap has increased from $712.90M to $839.11M, an increase of 17.70%. That is a compound annual growth rate of 4.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 839.10M | 59.49% |
| Dec 29, 2023 | 526.10M | 71.03% |
| Dec 30, 2022 | 307.60M | 31.68% |
| Dec 31, 2021 | 233.60M | -82.32% |
| Dec 31, 2020 | 1.32B | 85.37% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OPKO Health | 857.30M |
| Cogent Biosciences | 854.78M |
| Abivax | 853.16M |
| Relay Therapeutics | 849.55M |
| Dianthus Therapeutics | 847.32M |
| Viridian Therapeutics | 843.10M |
| HealthStream | 838.07M |
| AbCellera Biologics | 817.47M |